Loading clinical trials...
Loading clinical trials...
Phase II Study of Radiotherapy in Combination With Chemotherapy and Immunotherapy in Patients With PD-L1-Positive Metastatic Triple-Negative Breast Cancer
Conditions
Interventions
Nab-paclitaxel
Paclitaxel
+2 more
Locations
1
United States
University of Colorado Hospital
Aurora, Colorado, United States
Start Date
January 4, 2022
Primary Completion Date
December 1, 2022
Completion Date
December 1, 2022
Last Updated
December 6, 2022
NCT07347600
NCT06681064
NCT05005403
NCT06547840
NCT04704661
NCT05372640
Lead Sponsor
University of Colorado, Denver
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions